Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: NMR Biomed. 2021 Oct 5;35(1):e4621. doi: 10.1002/nbm.4621

Improving D-2-hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF-receive/B0-shim array coils at 3 T

Bernhard Strasser 1,2, Nicolas S Arango 3, Jason P Stockmann 1,4, Borjan Gagoski 5,6, Bijaya Thapa 1, Xianqi Li 1, Wolfgang Bogner 2, Philipp Moser 2, Julia Small 7, Daniel P Cahill 7, Tracy T Batchelor 8, Jorg Dietrich 8, Andre van der Kouwe 1,4, Jacob White 3, Elfar Adalsteinsson 3,9, Ovidiu C Andronesi 1,4
PMCID: PMC8717863  NIHMSID: NIHMS1764742  PMID: 34609036

Abstract

MR spectroscopic imaging (MRSI) noninvasively maps the metabolism of human brains. In particular, the imaging of D-2-hydroxyglutarate (2HG) produced by glioma isocitrate dehydrogenase (IDH) mutations has become a key application in neuro-oncology. However, the performance of full field-of-view MRSI is limited by B0 spatial nonuniformity and lipid artifacts from tissues surrounding the brain. Array coils that multiplex RF-receive and B0-shim electrical currents (AC/DC mixing) over the same conductive loops provide many degrees of freedom to improve B0 uniformity and reduce lipid artifacts. AC/DC coils are highly efficient due to compact design, requiring low shim currents (<2 A) that can be switched fast (0.5 ms) with high interscan reproducibility (10% coefficient of variation for repeat measurements). We measured four tumor patients and five volunteers at 3 T and show that using AC/DC coils in addition to the vendor-provided second-order spherical harmonics shim provides 19% narrower spectral linewidth, 6% higher SNR, and 23% less lipid content for unrestricted field-of-view MRSI, compared with the vendor-provided shim alone. We demonstrate that improvement in MRSI data quality led to 2HG maps with higher contrast-to-noise ratio for tumors that coincide better with the FLAIR-enhancing lesions in mutant IDH glioma patients. Smaller Cramér–Rao lower bounds for 2HG quantification are obtained in tumors by AC/DC shim, corroborating with simulations that predicted improved accuracy and precision for narrower linewidths. AC/DC coils can be used synergistically with optimized acquisition schemes to improve metabolic imaging for precision oncology of glioma patients. Furthermore, this methodology has broad applicability to other neurological disorders and neuroscience.

Keywords: D-2-hydroxyglutarate, glioma brain tumor, isocitrate dehydrogenase mutations, magnetic resonance spectroscopic imaging, multicoil shimming, multiplexed RF-receive and B0-shim array, precision oncology

1 |. INTRODUCTION

Spatial mapping of brain metabolism by 3D MRSI provides comprehensive evaluation of tumor burden with higher specificity than anatomical imaging, which is valuable to guide treatment planning and assess treatment response.15

D-2-hydroxyglutarate (2HG) is an oncometabolite produced by tumors with point mutations in the isocitrate dehydrogenase (IDH) enzymes IDH1 and IDH2.6 IDH mutations are highly frequent in lower grade gliomas7 and produce high concentrations (>1 mM) of 2HG, which can be used as a biomarker for diagnosis and monitoring of tumor evolution. In vivo MRS can noninvasively measure 2HG concentrations in mutant IDH glioma patients,811 which has become a key clinical application in neuro-oncology.

Although 2HG theoretically has a very high contrast-to-noise ratio (CNR) between mutant IDH tumor and healthy brain where it is virtually absent, the detection of 2HG by in vivo MRS is complicated by low signal-to-noise ratio (SNR), and spectral overlap with abundant brain metabolites such as glutamate, glutamine, myo-inositol, and creatine. Optimized sequences for 2HG measurements at 3 T have been introduced,3,816 but the ability to fit and separate 2HG from the brain metabolic background critically depends on spectral quality. Spectral linewidths of narrower than 0.1 ppm are required, which is the separation between 2HG and glutamate and glutamine. This requirement is challenging to fulfill uniformly over the entire brain due to local B0 inhomogeneities, and it is even more challenging in brain tumor patients due to blood in the tumor, surgical cavities, or metal implants postsurgically.

Additionally, the SNR of the 2HG signal is low, and to boost SNR large voxels or long measurement times are necessary. While long measurement times (>10 min) are prohibitive in routine clinical investigations, low spatial resolution leads to strong lipid artifacts for unrestricted field of view (FOV) MRSI, especially if no outer-volume suppression methods are employed, thereby preventing reliable 2HG quantification. On the other hand, restricting the FOV by inner volume selection and outer-volume suppression provides only partial brain coverage, is difficult to prescribe, and misses tumor regions towards the brain periphery.

Methods that correct B0 inhomogeneity using active shimming1723 or during postprocessing2426 can improve MRSI data quality. In cases of severe B0 distortions, the use of advanced shimming hardware with high order spherical harmonics18 or multicoil arrays19 is indispensable to adequately recover spectral linewidth. Integrated radio frequency (RF)-receive and B0-shim coil arrays20,21 multiplex AC and DC electrical currents through the same set of conductive wire loops to simultaneously receive RF signal (AC) and generate independent ΔB0 spatial field patterns (DC). They provide degrees of freedom for high spatial order B0 shimming in the brain,19,27 supplementing the scanner’s standard second-order spherical harmonics (2SH) shim, while maintaining the high RF-receive sensitivity of the 32-channel receive array. Hence, such AC/DC coil arrays enable improved linewidths over large brain volumes for 3D MRSI, as has been recently shown at 7 T.28,29 As a result of their small size, low inductance, and distance to conductive metal structures in the bore, these shim coils can be switched rapidly within a single TR28 without inducing eddy currents. This allows ΔB0 field patterns to switch and alternate between lipid suppression and metabolite acquisition to maximize the performance of each sequence module. Shaping the B0 field in the scalp during lipid suppression, either to shift the fat frequency28,30 or to spoil the fat signal,31 has been shown to reduce lipid artifacts in MRSI. Thus, by simultaneously improving linewidths and lipid suppression, AC/DC coils enable 3D MRSI over a thick brain slab at a spatial resolution that optimizes scan time, SNR, and linewidths for a clinically feasible protocol.

Based on simulations, we hypothesized that the ability to detect and quantify 2HG from 3D MRSI in mutant IDH glioma patients will be improved by using an AC/DC coil. Motivated by the high clinical value of 2HG imaging for glioma patients, we demonstrate the feasibility of first clinical applications of AC/DC coils.

2 |. EXPERIMENTAL

Our methodology was developed and implemented on a 3-T Skyra scanner (Siemens Healthcare, Erlangen, Germany). Details of the pulse sequence are presented in Figure 1.

FIGURE 1.

FIGURE 1

(A) 32-channel AC/DC coil (left) and shim control boards (right); (B) Pulse sequence diagram showing the dynamic shim update. Arrows indicate the times at which the different dynamic shims are applied; (C) Histogram of fat and N-acetyl aspartate (NAA) frequency distribution in the scalp layer and brain compartment, respectively, for standard 2SHBox shimming (top) and fat suppression shimming (bottom). The hypergeometric single band (HGSB) inversion profile is shown by the red line and the transition band by the gray boxes. An offset of 0 Hz corresponds to the frequency of tetramethylsilane

2.1 |. Multicoil shimming hardware and software

We employed recently developed multicoil dynamic shimming hardware consisting of a 32-channel “AC/DC” coil array patterned on a 3D printed helmet, as described in20 (Figure 1A). The helmet is 22.5 cm high in the A/P, and 19 cm wide in the R/L dimension, which fits about 90% of the healthy adult population. RF-receive loops with a diameter of 9.5 cm made of AWG16 solid wire are arrayed in a hexagonal–pentagonal pattern, with critical overlap to decouple neighboring elements. Toroidal inductive chokes are used to bridge DC shim current into each RF-receive loop, thus adding B0 field control capability to each element in the array. In this way, the array provides both RF-receive and B0 shimming functionality with high efficiency by placing the loops close to the brain, where they operate with high efficiency for both signal reception and generating B0 field offsets. Shim currents were driven by a bank of digitally programmable low-voltage amplifiers that allows very fast switching under 1 ms between different B0 field offsets.28,32 The output stage devices are mounted to heat sinks with in-laid piping for optional water cooling. For further details of the AC/DC array hardware and shim amplifiers, we refer the reader to the references,20,32 respectively.

For MRSI measurements, the AC/DC shims were dynamically switched between a metabolite homogeneity B0 shim (ACDCmet) during data acquisition, and a fat suppression B0 shim (ACDCfat) during fat suppression. Whenever these two fields are dynamically switched within the same sequence, they are referred to as ACDCmet|fat. The ACDCmet and ACDCfat were independently optimized on top of the 2SH shim. Because the different shims are calculated for different volumes, we further indicate the shim volume by appending “Box”, “Brain”, or “Scalp” to the shim names as subscripts (e.g. 2SHBox + ACDCmetBrain|fatScalp). The “Box” shim is a rectangular volume that covers the whole excited slab, and includes the brain, scalp, and skull. The “Brain” shim volume includes only the brain without the skull or scalp, while the “Scalp” shim volume includes only the fat-containing scalp layer.

For calculating the 2SHBox shim, three shim-iterations with the manufacturer’s dual echo steady state (DESS) sequence were used. Empirically, using several shim-iterations improves the B0-homogeneity in comparison with a single iteration. For calibrating the AC/DC shim coils, a standard two-echo gradient echo B0 mapping sequence was used to measure the B0-fields caused by each individual AC/DC shim coil in a large phantom. During the subject measurements, B0 fieldmaps were measured after applying the 2SHBox shim using the same sequence. The phase difference image was spatially unwrapped with FSL PRELUDE33 and converted to a B0-fieldmap. The optimal shim currents for the 32 shim channels were computed using offline custom optimization software implemented in MATLAB (MathWorks, Natick, MA, USA). A single shim-iteration was performed as follows. For the ACDCmetBrain, DC shim currents were calculated using a least squares penalty on the remaining ΔB0 (after shimming with the 2SH-shim) with the goal of minimizing the standard deviation of the ΔB0 within the shim volume. The linearly constrained, quadratic objective optimization problem for brain homogeneity is solved using MATLAB’s built-in quadratic program solver, quadprog. The convex, linear optimization problem for lipid suppression is solved using MATLAB’s linear program solver, linprog (more details are given in Supplementary Information). Shim currents were automatically calculated in less than 1 min through solution of the optimization problems.

When using the 2SH-shim as a preshim for the ACDCmetBrain, a higher B0-homogeneity can be achieved than when using only the ACDCmetBrain, with the disadvantage of increasing the preparation time. The three shim iterations for the 2SH preshim took about 80–120 s in total, while both ACDC shims (measurement + calculation time) took about 130 s, resulting in a total time of about 210 s. However, the calculation of the 2SH-shims and ACDC-shims could be performed simultaneously, and based on the same B0-maps, which would almost eliminate the additional time demand of the 2SH preshim. For the ACDCfatScalp, the DC currents were jointly optimized along with the transition frequency of the lipid suppression pulse, with the goal of minimizing the number of voxels containing unsuppressed lipids in the scalp compartment and incidentally suppressed NAA in the brain compartment. This procedure has the effect of widening the spectral interval between spatially separated lipids and NAA beyond their intrinsic 0.7-ppm gap. More details can be found in supporting information file S1. Figure 1C illustrates such an increased spectral gap between the 1.3-ppm lipid peak and NAA, while supporting information file S2 shows the case for the 2.24-ppm lipid peak. The application of the ACDCfatScalp and ACDCmetBrain shims was triggered dynamically within each TR by the pulse sequence, as shown in Figure 1B.

In summary, our proposed shim methodology consists of four components: (1) the standard 2SH-shim, which provides the constant “baseline” shim; (2) the AC/DC coil, which adds localized ΔB0 fields; (3) the capability to dynamically switch those AC/DC fields within each TR, allowing to separately optimize the shim for metabolite detection and lipid suppression; and (4) our shim software, which more readily than the scanner’s shim software allows to shim only the brain instead of the whole head.

2.2 |. Data acquisition and processing

Our MRSI sequence34 used an adiabatic spin-echo (ASE) excitation for axial slab selection and a stack-of-spirals for 3D k-space encoding, as shown in Figure 1B. Because ASE is double refocusing, similar to PRESS, we optimized it for 2HG detection using TE1/TE2 = 32/65 ms.9 We verified by simulations (Figure 2) that ASE at TE = 97 ms produces 2HG phase modulations similar to PRESS at TE = 97 ms, as described by Choi et al.9 ASE uses adiabatic RF pulses of larger bandwidth compared with PRESS, and which reduce the chemical shift displacement error by 20-fold, provide more uniform and sharper slab excitation, and also compensate for B1 inhomogeneity. The ASE used a BIR-4 adiabatic excitation pulse35 and two adiabatic gradient offset independent wideband uniform rate and smooth truncation (GOIA-W)(16,4) refocusing pulses.36 Lipid suppression was achieved with inversion recovery using a hypergeometric single band (HGSB) pulse37 for selective adiabatic inversion of the main lipid peaks at 1.3 and 0.9 ppm. An inversion time (TI) of 210 ms was used for fat nulling, which is close to the TI used at 3 T.38 The HGSB pulse had a wide inversion bandwidth of 2 kHz and a narrow transition band of 48 Hz (0.4 ppm at 3 T), which is smaller than the separation (0.7 ppm) between the main peaks of NAA (2 ppm) and lipids (1.3 ppm). The wide inversion bandwidth is necessary, because the 2SHBox + ACDCfatScalp broadens the lipid frequency range. Details regarding all the pulses can be found in the supporting information file S3.

FIGURE 2.

FIGURE 2

Effect of increasing the linewidth on fitting simulated brain tumor spectra that contained 14 brain metabolites and D-2-hydroxyglutarate (2HG): (A) Tumor spectra containing 2 mM 2HG, and (B) Tumor spectra containing 5 mM 2HG. The effect of increasing linewidths on the precision and accuracy of 2HG quantification in simulated spectra: (C) Cramér–Rao lower bounds (CRLB) values are indicative of precision, and (D) the ratio between the true and fitted concentration is indicative of accuracy. Spectra were simulated in GAMMA for the ASE sequence assuming TE = 97 ms (TE1/TE2 = 32/65 ms) and a 3-T B0 field. LCModel fitting (A, B) is shown in red overlaid on the simulated spectra shown in black in the upper four rows, and below, the fitted 2HG contribution in each spectrum is shown for the four linewidths. Trend lines (dashed) are shown in (C, D), and the 20% CRLB threshold for goodness of fit is indicated by the dashed line in (C), while the ground truth value is shown by the dashed line drawn at 1 in (D)

The HGSB inversion profile and histogram of NAA and fat frequencies are shown in Figure 1C. As a result of the widened NAA-fat gap, the HGSB transition band hardly overlaps with the fat frequencies in the case of the 2SHBox + ACDCfatScalp, while it partially overlaps for the 2SHBox shim. The center of the HGSB transition band was set to 1.6 ppm for 2SH shimming, providing no inversion above 1.8 ppm and full inversion below 1.4 ppm. For the 2SHBox + ACDCfatScalp shim, the center frequency of the HGSB pulse was set according to the measured frequency shift of the fat layer with the optimized 2SHBox + ACDCfatScalp applied. After HGSB lipid inversion and before water suppression, the AC/DC coil was switched to the ACDCmetBrain shim, which was maintained during metabolite excitation and acquisition until the next HGSB pulse. The water suppression enhanced through T1 effects (WET)39 was inserted during the inversion recovery TI, and immediately before the beginning of the ASE excitation. The following sequence parameters were used: TE1/TE2/TR/TI = 32/65/1800/210 ms, 3D stack-of-spirals (maximum gradient amplitude per direction: 11.09 mT/m, maximum slew rate per direction: 127 mT/m/ms), FOV 240 × 240 × 100 mm3, volume of interest 240 × 240 × 50 mm3, matrix size 24 × 24 × 10, nominal voxel size 1 cm3, 1100 Hz spectral bandwidth, two temporal interleaves, four angular interleaves, four averages (cosine-weighted in z-direction), and a total acquisition time of 5 min 24 s. In all subjects, the shim volumes were similarly chosen.

In addition to previous work,28 we inserted an interleaved EPI-based volumetric navigator into our 3D MRSI sequence, which was played every TR before lipid inversion for real-time motion and frequency drift correction.40

B0-fieldmaps and anatomical imaging with FLuid-Attenuated Inversion Recovery (FLAIR), and multiecho-MPRAGE (MEMPRAGE),41 were also acquired. B0-fieldmaps were acquired with a 2D two-echo gradient echo sequence with a resolution of 2 × 2 × 2 mm3, slice gap of 2 mm, FOV of 220 × 220 × 160 mm3, and TEs of 5 and 7.46 ms. The ΔTE of 2.46 ms ensures that water and the main lipid peak around 1.3 ppm are in phase at 3 T, so that the chemical shift between water and the primary lipid peak does not influence the image phase and thus the derived ΔB0-maps.

All MRSI data were phase-corrected to account for the fact that different spiral k-space points were acquired at different time points42 and density-compensated in k-space.43 Afterwards, the data were gridded to Cartesian k-space points using a Kaiser–Bessel kernel,44 Fourier-transformed, coil combined using a sensitivity map, Hamming-filtered in the in-plane k-space, and finally processed with LCModel.45 The Hamming filter increased the effective voxel size by a factor of 1.53 over the effective unfiltered size. Default LCModel parameters were used to fit the 1.8–4.2 ppm range, except that LCModel was not allowed to simulate peaks, the uncertainty of the zero- and first-order phases were set to 20, and the residual water peak was used for estimating the frequency shifts. A basis set for ASE was simulated in GAMMA46 (supporting information file S4). Metabolic maps were converted to pseudo-absolute concentrations by taking the mean total creatine (tCr) signal scaled by the slice-by-slice gray and white matter distribution, while assuming a tCr concentration of 7 mmol/kg in white and 8.6 mmol/kg in gray matter.47 The tCr concentration was also compared between the tumor and the normal appearing brain to test whether tumors could pose a problem for these assumptions. Brain segmentation was performed on the anatomical images using FAST,48 and the segmented images were downsampled in k-space and Hamming-filtered to match the MRSI acquisition. All voxels of all slices within the volume of interest and with CSF contributions of less than 50% were analyzed in quantitative comparisons.

2.3 |. Spectral simulations

All simulations for the ASE spectra were performed using the GAMMA46 library, and using the same exact waveform modulations for all RF and gradient pulses, and the echo times as played by the scanner during the ASE pulse sequence. During the RF pulses the spin evolution was calculated with the time-dependent Liouville–von Neumann density matrix equation using a piece-wise constant Hamiltonian with a time step of 10 μs, which is the same as the gradient raster-time of the scanner. We verified that the 10-μs time step was sufficient in simulations and produced the same results with shorter time steps of 1 μs. The NMR interactions (chemical shift and scalar couplings) corresponding to the spin system of each metabolite were used from the literature.49,50

To account for localization and slice profile errors of the GOIA pulses, a slab of 50-mm thickness was assumed to be selected in the middle of a one-dimensional, 100-mm long object. The object was divided into 1000 very thin sections. The number of thin sections was verified to be sufficient as further increases did not change the results. Note that a one-dimensional object is appropriate because the pair of GOIA pulses is used to select only along the slice direction. The offset (γzG) induced by the gradient was considered to be constant across an infinitesimal section and the spin evolution was calculated independently for each section, and finally the spectra from all the sections were averaged. Spectra were simulated assuming the same spectral window (dwell time) as used during acquisition, and the same carrier frequency for all the RF pulses. To speed up the simulations we used the symmetry of the RF and gradient waveforms.

2.4 |. Study design and data evaluation

In a first series of tests we investigated through simulations how reliably 2HG can be fitted in tumor spectra depending on the spectral linewidth. In the second series of tests, we compared our proposed shim methodology with the vendor-provided shim. In total, nine human subjects were imaged for testing, as detailed below.

For the first series of tests, we performed simulations of brain tumor spectra for different spectral linewidths, assuming ASE excitation. Synthetic tumor spectra were obtained by combining simulated spectra of 14 brain metabolites and 2HG (supporting information file S5). Two cases were considered for 2HG concentration: 2 and 5 mM. To mimic the effects of B0 inhomogeneity, we applied line broadening in the range of 0.008–0.243 ppm with a 0.008-ppm step size; 10% white noise was added after line broadening in all simulations. The simulated spectra were fitted with LCModel45 equivalently to experimental spectra. The 2HG Cramér–Rao lower bounds (CRLB) and the 2HG concentration error between the fitted and the ground truth values were investigated.

For the second set of comparisons performed in all subjects, the MRSI sequence and B0-maps were measured twice under two different shimming situations: (1) using 2SHBox shimming, and (2) using the dynamic 2SHBox + ACDCmetBrain|fatScalp. This comparison was deemed the most relevant because it compares the AC/DC shimming with the manufacturer shimming available to all users. Due to time restrictions, volunteer 4 and patient 4 were only measured with 2SHBox and 2SHBox + ACDCmetBrain shims. To characterize improvements in spectral quality, several metrics were used: (1) linewidths; (2) SNRs; (3) CRLB of 2HG estimated by LCModel; and (4) lipid content, estimated by summing the magnitude spectra in the range 2.3–0.3 ppm. Wilcoxon rank-sum tests were used to test for statistical differences between both shim conditions. To characterize improvements in 2HG image quality, the following metrics were used: (1) the coefficients of variation (CVs) of 2HG inside and outside of tumors; and (2) the contrast-to-noise ratio, CNR=mean(2HGTumor)mean(2HGBackground)std(2HGBackground), where background represents the normal appearing brain outside the tumor. Tumor regions were outlined on the FLAIR images.

Furthermore, we investigated the contribution of the shim volume for improving B0 shimming and the shimming repeatability (supporting information files S6 and S7).

2.5 |. Human subjects

Five healthy control volunteers and four mutant IDH1 glioma patients (two males and two females, aged 28, 31, 34, and 41 years) were measured to test our methodology. All four patients had IDH-mutated tumors, as confirmed by immunohistochemistry.51 Informed consent was obtained from each subject, and the local institutional review board approved the study. Patient 1 had an IDH1-R132H mutated glioblastoma, which was partially resected 2 weeks before the measurement. This patient posed challenges for MRSI by postsurgical changes that strongly decreased B0-homogeneity in the residual tumor due to a large accumulation of blood products in the surgical cavity, and a large titanium metal plate for skull repair. Patient 2 was scanned one day presurgically and presented with a small FLAIR lesion that was confirmed postsurgically to be a diffuse astrocytoma with IDH1-R132H mutation. However, this patient had very low mutant IDH1 cell density by immunohistochemistry staining, suggesting an early-stage tumor with very low 2HG concentrations.4 In both patients 1 and 2, the tumor had a frontal location at the anterior pole close to the frontal sinuses, which is very challenging for B0 shimming. Patient 3 had a fronto-parietal residual tumor postsurgery, and patient 4 had a temporal tumor presurgically.

3 |. RESULTS

The effects of increasing linewidths on the 2HG fitting are shown in Figure 2 for simulated spectra. For narrow linewidths of 0.081 ppm or less, a rich spectral pattern can be observed in the 2.1–2.5 ppm range (Figure 2A,B). For broad linewidths of 0.138 ppm or more, the characteristic spectral pattern is lost by blurring and partial signal cancellation. The specific 2HG signal at 2.25 ppm is not fitted at all in broad spectra for 2 mM concentration (Figure 2A, bottom row). The effects of linewidth on 2HG quantification errors are shown in Figure 2C,D. The relative CRLB (Figure 2C) remain under 20% for linewidths of less than 0.1 ppm, but sharply increase at linewidths of 0.12 ppm or more for 2 mM concentration, and for linewidths of 0.15 ppm or more for 5 mM concentration. The ratio between estimated and true concentrations (Figure 2D) is closer to 1 for linewidths of less than 0.12 ppm and approaches 0 for increasing linewidths. The detrimental effect of increasing linewidths is more pronounced at low 2HG concentrations, and the ability to estimate 2 mM is completely compromised for linewidths of 0.12 ppm or more.

Figure 3 shows the B0-maps of patient 2, together with the linewidth map, and examples of spectra for the standard 2SHBox and the 2SHBox + ACDCmetBrain|fatScalp shim conditions. Improvements in spectral quality with the 2SHBox + ACDCmetBrain|fatScalp are visually obvious. The example of the 2SHBox spectrum #1 displays a broad linewidth that results in a large peak overlap of tCr at 3.0 ppm and total choline at 3.2 ppm. By contrast, the 2SHBox + ACDCmetBoxjfatScalp spectrum #1 shows a narrower linewidth with clearly separated peaks. In addition, both spectra show examples where the improved lipid suppression by the 2SHBox + ACDCmetBrain|fatScalp shimming results in a flatter baseline in comparison with the 2SHBox shim.

FIGURE 3.

FIGURE 3

Measured B0-maps of patient 2 acquired with the 2SHBox and with the 2SHBox + ACDCmetBrain (first column). As a result of the higher B0-homogeneity, the average spectral linewidth was decreased with the 2SHBox + ACDCmetBrain|fatScalp (second column). Arrows indicate the position of the sample spectra (right two columns). The 2SHBox + ACDCmetBrain|fatScalp spectrum #1 shows significantly narrower linewidth, while spectrum #2 displays narrower linewidth and a flatter baseline due to the improved lipid and water suppression in the dynamic 2SHBox + ACDCmetBrain|fatScalp condition. Fat contamination is especially visible in spectrum #1 with 2SHBox. LCModel fitting shown in red is overlaid on the measured spectra (black)

Quantitative analysis revealed that the average linewidth decreased by 19% from 0.103 ± 0.046 to 0.083 ± 0.044 ppm (p < 0.001) for patients, and by 18% from 0.091 ± 0.041 to 0.074 ± 0.036 ppm (p < 0.001) for volunteers. The average SNR slightly increased from 13.5 ± 6.4 to 14.2 ± 6.4 (p < 0.05) for patients, and by 9% from 16.1 ± 6.9 to 17.6 ± 6.7 (p < 0.001) for volunteers. The lipid content inside the brain decreased by 23% on average for patients (p < 0.001), and by 21% for volunteers (p < 0.001), when using the 2SHBox + ACDCmetBrain|fatScalp versus the 2SHBox shimming. It is important to realize that these are not the absolute lipid suppression factors (i.e. not the comparison of fat suppression with no suppression), but the improvements with the 2SHBox + ACDCmetBrain|fatScalp over the 2SHBox shim. Examples of lipid maps are shown in Figure 4.

FIGURE 4.

FIGURE 4

Lipid maps for the standard 2SHBox shim and the 2SHBox + ACDCmetBrain|fatScalp for patient 1 and volunteer 1 together with the MEMPRAGE images. A decrease in the lipid content is clearly visible for both subjects for the 2SHBox + ACDCmetBrain|fatScalp in comparison with the 2SH shim. The lipids in 2SHBox + ACDCmetBrain|fatScalp were decreased to 0.43 ± 0.49 (mean ± std) of the 2SHBox values for those two subjects. Lipid maps are given in arbitrary units

The tCr concentrations in the tumor were estimated to be 6.7 ± 2.1 mM, while outside of the tumor they were 6.3 ± 1.9 mM. Both values seem to be slightly affected by CSF, but are very similar.

Figure 5 shows the 2HG concentration and CRLB maps of patients 1, 3, and 4 together with the FLAIR images in transversal and sagittal views. The shim volumes are indicated by green (box and metBrain) and red (fatScalp) overlays over the FLAIR images. The resection cavity of patient 1 has very bright FLAIR contrast due to blood products from the surgery. In the case of 2SHBox + ACDCmetBrain|fatScalp of patient 1, an area of high 2HG with low CRLB values can be clearly seen in the residual tumor tissue located posterior and superior to the surgical cavity with little background signal outside the tumor. For the 2SHBox shim case, the area of detectable 2HG near the tumor is smaller, and there are areas with high 2HG in the anterior brain or on the contra-lateral side disagreeing with the FLAIR-enhancing tumor. Patients 3 and 4 also show 2HG increases in the tumor regions, although in patient 3 this is less pronounced than in patients 1 and 4. In the case of the 2SHBox shim condition, high 2HG coincide less with the FLAIR-enhancing regions, with high foci far away from the tumor. The error in 2HG fitting decreased in all three patients with AC/DC shimming, as the CRLB maps show lower values in the tumor area for 2SHBox + ACDCmetBrain|fatScalp than for 2SHBox. The CNR of 2HG maps improved substantially from 0.11 ± 0.05 with 2SHBox shimming to 1.45 ± 0.74 with the 2SHBox + ACDCmetBrain|fatScalp. The red arrows in patient 1 indicate the positions of the spectra (shown in supporting information file S8) from a voxel within the tumor and a voxel located in the healthy appearing brain from the contralateral hemisphere. These spectra demonstrate a significant improvement in quality when using the 2SHBox + ACDCmetBrain|fatScalp over the 2SHBox shim condition. The mean linewidth in the tumor voxels of patients 1, 3, and 4 was reduced from 0.097 ± 0.037 to 0.076 ± 0.024 ppm (p < 0.001). The 2SHBox + ACDCmetBrain|fatScalp linewidths are in the range where simulations indicated acceptable estimation for 2HG concentration, which is confirmed experimentally here, showing a clearer 2HG signal contribution (overlaid in red). Results of the quantitative analysis are summarized in Table 1. Figure 6 shows axial 2HG maps for patient 2 and two volunteers. No 2HG increase could be detected in the tumor of patient 2 for both shim conditions, with 2HG CNR values of −0.76 for the 2SHBox shim and −0.45 for the 2SHBox + ACDCmetBrain|fatScalp. In healthy subjects and patient 2, fewer areas with high 2HG concentrations were present in the healthy brain for the 2SHBox + ACDCmetBrain|fatScalp, resulting in fewer 2HG foci disagreeing with FLAIR-enhancing tumors. This is reflected by a decrease in the CV of 2HG by 63%. Within the tumors of patients 1, 3, and 4, the CV decreased by 40% for the 2SHBox + ACDCmetBrain|fatScalp. The mean 2HG CRLB inside the tumors of patients 1, 3, and 4 were below 40% only for the 2SHBox + ACDCmetBrain|fatScalp. For patient 2, neither shim condition achieved CRLB below 40% inside the tumor.

FIGURE 5.

FIGURE 5

D-2-hydroxyglutarate (2HG) maps obtained by 2SHBox shim and the 2SHBox + ACDCmetBrain|fatScalp in patients 1, 3, and 4. Absolute 2HG concentrations were calculated by normalizing to the mean total creatine (tCr) signal. Cramér–Rao lower bounds (CRLB) maps are shown with 50% maximum threshold. Low CRLB in the tumor are obtained in particular with the 2SHBox + ACDCmetBrain|fatScalp. Red arrows indicate the spectra location shown in Figure S2. The shim volumes are shown in green (2SHBox and ACDCmetBrain) and red (ACDCfatScalp) overlaid on the FLAIR. The red lines indicate the positions of the shown transverse slices. 2HG maps with the native resolution are shown in supporting information file S9 together with the interpolated resolution

TABLE 1.

Comparison of parameters obtained with standard vendor implemented 2SHBox shimming alone and with the combined 2SHBox + ACDCmetBrain|fatScalp shimming

Shim method # Vox [] LW [ppm] SNR [] Fat [%] 2HG tumor CRLB [%] 2HG tumor CNR []
2SHBox Vol 2210 0.091 ± 0.041 16.1 ± 6.9 100 ± 158 N/A N/A
Pat 1475 0.098 ± 0.043 14.2 ± 6.5 100 ± 167 300 ± 430 0.11 ± 0.05
2SHBox + ACDCmetBrain|fatScalp Vol 2210 0.074 ± 0.036 17.6 ± 6.7 79 ± 130 N/A N/A
Pat 1475 0.080 ± 0.041 13.9 ± 6.0 30 ± 39 39 ± 74 1.45 ± 0.74

Note: Numbers for LW, SNR, and fat contamination represent mean and std (where applicable) values averaged over either patients (Pat) or volunteers (Vol) and all brain voxels. The fat contamination was calculated relative to standard 2SHBox shimming, which was assumed to have 100% contamination. The values for CRLB were calculated for 2HG only in the tumor areas of patients 1, 3, and 4 that have detectable 2HG levels by MRSI. Similarly, the CNR was calculated based on the patients 1, 3, and 4 with detectable 2HG levels by MRSI.

Abbreviations: 2HG, D-2-hydroxyglutarate; CNR, contrast-to-noise ratio; CRLB, Cramér–Rao lower bounds; Fat, contamination with scalp lipid signals; LW, linewidth; SNR, signal-to-noise ratio.

# Vox, the number of total voxels pooled over all considered subjects.

FIGURE 6.

FIGURE 6

D-2-hydroxyglutarate (2HG) maps obtained by 2SHBox shim and the 2SHBox + ACDCmetBrain|fatScalp in patient 2 and volunteers 1 and 2. With standard 2SHBox shimming, high 2HG foci can be seen in random locations throughout healthy brain and far from the tumor in the patient. The 2HG maps show fewer remote foci outside the tumors with the 2SHBox + ACDCmetBrain|fatScalp shim. Patient 2 had a low-grade small tumor with a very low density of mutant IDH1-R132H cells and its 2HG levels are expected to be very close to the normal background. The shim volumes are shown in green (2SHBox and ACDCmetBrain) and red (ACDCfatScalp) overlaid on the FLAIR or MEMPRAGE. The red lines indicate the positions of the shown transverse slices. 2HG maps with the native resolution are shown in supporting information file S9 together with the interpolated resolution

Figure 7 shows that the 2SHBox + ACDCmetBrain|fatScalp also improves the quantification of other metabolites, such as glutamate and glutamine (Glx), NAAG, and total NAA (tNAA). With the 2SHBox shim, random foci in the metabolic maps are visible for patient 2. With the 2SHBox + ACDCmetBrain|fatScalp, the metabolic maps show a better agreement with the underlying anatomical images. Volunteer 2 provides an example of where the 2SHBox + ACDCmetBrain|fatScalp only modestly improved the quantification of these three metabolites, because the data quality was already sufficient in the 2SHBox case.

FIGURE 7.

FIGURE 7

Glx, NAAG, and tNAA maps for volunteer 2 and patient 2 overlaid on MEMPRAGE images. This figure shows a clear improvement in metabolic maps other than 2HG when using the 2SHBox + ACDCmetBrain|fatScalp shim compared with the 2SHBox shim only. In patient 2 there is more spatial variability in 2SHBox metabolic maps with foci of high and low intensity in random locations, while 2SHBox + ACDCmetBrain|fatScalp metabolic maps correspond better to brain anatomy and tumor location. Volunteer 2 provides an example of where the improvement by the 2SHBox + ACDCmetBrain|fatScalp shim is smaller, because the data quality was already sufficient in the 2SH case. Glx, glutamate + glutamine; NAAG, N-acetylaspartylglutamic acid; tNAA, NAA + N-acetyl-aspartyl-glutamate

Additional results related to region of interest (ROI) selection, stability, and repeatability for 2SH and AC/DC shimming, are provided in the supporting information.

4 |. DISCUSSION

In this first clinical application of AC/DC coils at 3 T we showed that 3D imaging of 2HG is feasible at resolutions of 10-mm isotropic over an unrestricted in-plane FOV of the brain with the benefit of short acquisition times and high SNR, but without the usual penalties of lipid contamination or large linewidths normally associated with such resolutions. This was achieved by using an AC/DC coil in combination with an adiabatic dual-refocusing stack-of-spirals 3D MRSI sequence optimized for 2HG detection, including an interleaved volumetric navigator for real-time motion and frequency correction. We investigated the influence of the AC/DC methodology on metrics such as the global B0-homogeneity, local spectral linewidth, SNR, and lipid suppression. The net effects of higher spectral quality were lower CRLB for 2HG quantification and a better overlap of high 2HG with the tumor regions outlined by FLAIR images in three of the four patients. Simulations indicate that 2HG is underestimated for linewidths of 0.12 ppm or more, particularly for low 2HG concentrations. This might be clinically very relevant, because low 2HG concentrations can occur in patients with incipient tumors, where early cancer detection is critical, or in patients after surgical resection, for which monitoring of residual tumor is required. The first patient that was scanned shortly after surgery posed the greatest challenges for MRSI data quality through a combination of several factors: (1) anterior pole frontal tumor location close to sinuses and air cavities; (2) large accumulation of blood products with paramagnetic Fe2+ from deoxyhemoglobin; and (3) a titanium plate for skull repair and fiducials for radiotherapy. Due to these challenges, the 2SHBox shim resulted in a 2HG image with high foci that disagree and are remotely outside the FLAIR-enhancing tumor. The 2SHBox + ACDCmetBrain|fatScalp shimming improved the 2HG maps in patients 1, 3, and 4, with higher 2HG signal in the tumor and less variability outside the tumor. With the 2SHBox + ACDCmetBrain|fatScalp, the CNR of the tumors increased by 45% above the background, resulting in 2HG foci coinciding with the FLAIR-enhancing tumor. The second patient presented with the challenges of B0-inhomogeneity in the frontal pole tumor location and of presumably very low 2HG levels typically seen for small tumors with a low density of mutant IDH cells,4 as was confirmed using antimutant IDH immunohistochemistry staining. While the 2SHBox + ACDCmetBrain|fatScalp did not enhance the 2HG tumor contrast in this patient, it reduced the random foci of high 2HG background outside the tumor that were noticed with the 2SHBox shim. This result has also been replicated in healthy volunteers.

In a recent study11 that compared dual refocusing (PRESS, TE = 97 ms) and J-difference (MEGA-PRESS, TE = 68 ms) for 2HG detection, the dual-refocusing scheme required lower CRLB for an acceptable predictive value. In MRSI applications, CRLB of up to 50% for 2HG may be acceptable, because a cluster of voxels is typically obtained, and each voxel adds information about the presence or absence of 2HG. In single voxel spectroscopy (SVS), narrower spectral linewidths are usually obtained, and due to the lack of information from multiple locations, the CRLB threshold may need to be set as lower (e.g. 20%). The AC/DC shimming may enable this performance over larger brain volumes, for challenging tumor locations, and for a wider range of scanner platforms. The AC/DC coil allows 2HG imaging of an unrestricted FOV of the brain slab in a faster time (5 min 24 s) that is clinically more feasible compared with previous 3D (18 min 22 s in14 and 19 min in16) and 2D (13 min 20 s in15) 2HG imaging.

We demonstrate the utility of using convex optimization to jointly solve for the tailored B0 offset field and the HGSB inversion pulse transition frequency. While realized here using an integrated AC/DC coil array, any hardware capable of rapidly switchable local field control could be adapted for this application, such as spherical harmonics or stand-alone multicoil shim arrays. The lipid suppression depends on how well the specific shim coil can tailor the B0 field offsets to the specific skull shape of the subject, which improves with more degrees of freedom. Alternatively, it was recently shown by de Graaf et al.30 that using only a small number of high-amplitude pulsed 2SH coils improved lipid suppression by creating an elliptical B0 field that approximates the shape of the skull for single-slice MRSI, but may be challenging for a thick slab. Another hardware approach to lipid suppression includes a dedicated lipid crusher coil31 that creates a spoiling B0 field pattern in the scalp, but cannot improve B0 homogeneity in the brain.

We note that there are several differences in the shim calculation between our 2SHBox + ACDCmetBrain|fatScalp method and the vendor-provided 2SHBox shimming routine of our scanner: the B0 fieldmap sequences, the phase unwrapping algorithm, and the shim volume. Therefore, the reported improvements potentially stem not only from the AC/DC hardware itself, but also from the shim software and volume. We investigated this issue in supporting information file S6. In addition to,28 we incorporated a navigator into our MRSI sequence for real-time B0 field mapping to correct frequency drift and motion, as well as monitoring the stability of the AC/DC hardware.

Our study has some limitations. Although we performed immunohistochemistry staining in biopsies of all four tumor patients, we do not have ground truth 2HG concentrations, because immunohistochemistry staining cannot be used to determine 2HG levels. A meaningful validation would require a comparison between in vivo 2HG imaging and mass spectroscopy 2HG measurements from multiple biopsies collected throughout the entire volume of the brain, and ideally also outside the tumor in the normal appearing brain. Because this is not yet possible for us, we cannot verify our measured 2HG concentrations. Instead, we compared the spatial distribution of high 2HG concentrations with the FLAIR tumor hyperintensity, and noticed that there is greater agreement between high 2HG regions and FLAIR lesions in the case of 2SH + ACDC shimming. However, our presented 2HG maps show 2HG concentrations above zero also in regions outside the FLAIR-enhancing tumors. The reasons for this are unclear, but might be technical or biological in nature. Technical reasons may be related to residual lipid artifacts, which are fitted as 2HG. Further variability may be introduced by spiral-related artifacts, such as temporal interleaving artifacts, artifacts related to RF imperfections, the variability in tCr that is used for our absolute concentration estimates, or the point-spread function caused by the spiral acquisition and the used Hamming filter. The latter, in particular, may make 2HG foci (coinciding with the tumors, but also outside) appear larger than they are. It is also important to note that our absolute concentration values of 2HG are in fact only institutional units, due to the assumption of tCr concentration values, as well as T1- and T2-relaxation times. Furthermore, the study only shows improvements when using the AC/DC coil for our scanner, our choice of shim volumes, and our shim methodology. It is not clear how these results generalize to other settings. We limited the 3D coverage to a brain slab of 5-cm thickness because larger slabs strongly reduce the achievable separation between brain metabolites and scalp lipids during the 2SHBox + ACDCfatScalp shim, and also degrade achievable B0 homogeneity during the 2SHBox + ACDCmetBrain shim. However, our MRSI sequence is not limited to 5 cm, and a larger slab can be encoded within the same acquisition time. The AC/DC coil used a pre-existing loop geometry that was optimized for RF reception, rather than local B0 field control. A coil explicitly designed to jointly optimize RF reception, B0 homogeneity, and tailored lipid suppression may improve performance for thicker brain slabs. Furthermore, the B0-calibration of the individual AC/DC coils might be biased and noisy, thus limiting the achieved B0-fidelity. Improved B0-calibration sequences23 might further enhance our method in the future. Although it is not possible with our data to discriminate between improvements achieved by narrower linewidths or by improved lipid suppression, such a comparison has been performed in volunteers, and showed that both improvements are equally important.28 Also, our methodology does not improve lipid suppression above 2.24 ppm, but the 2SHBox + ACDCfatScalp can partially achieve inversion of lipid peaks of 2.25 ppm or less. Another limitation is that we did not jointly optimize the 2SHBox shim with the ACDCfatScalp or the ACDCmetBrain because the second-order 2SH shim currents of the scanner cannot be updated rapidly enough to dynamically switch with the ACDCmetBrain and the ACDCfatScalp.

5 |. CONCLUSIONS

Integrated RF-receive and B0-shim coil arrays can improve the spectral linewidth and lipid suppression for 3D MRSI of human brain in patients and healthy volunteers at 3 T. This facilitates the use of low-resolution MRSI to shorten the acquisition time and gain SNR for 2HG imaging, without the artifacts associated with low resolution and unrestricted FOV (i.e. broad spectral linewidths and lipid contamination). We show that the combination of dynamic AC/DC multicoil shimming, real-time navigators for motion and frequency correction, and optimized 3D MRSI for 2HG detection, is feasible in mutant IDH glioma patients, and hence has high potential for clinical translation. This methodology resulted in higher CNR for 2HG images, and a more reliable detection of 2HG inside the tumors. AC/DC coils complement other methods, and thus improve already optimized methods for 2HG detection or other metabolites. We expect that this novel methodology will enable precision oncology in glioma patients for treatment planning2 and assessment of treatment response to targeted therapies.1,3,5 Furthermore, this methodology is applicable to the study of other neurological diseases or in healthy subjects.

Supplementary Material

Supplementary Material

ACKNOWLEDGMENTS

Funding from the National Institutes of Health, National Cancer Institute (1R01CA211080 and 1R01CA255479 to O.C.A., 2P50CA165962 to T.T.B. and D.P.C.), National Institute for Biomedical Imaging and Bioengineering (R21EB017338, R00EB021349, and U24EB028984 to J.P.S.), and National Institute of Child Health and Human Development (HD085813, HD093578, and HD099846 to A.v.K). Bernhard Strasser was partially supported by a fellowship from Austrian Science Funds (J 4124-N36).

Funding information

National Institutes of Health, National Cancer Institute, Grant/Award Numbers: 1R01CA255479, 1R01CA211080, 2P50CA165962; National Institute for Biomedical Imaging and Bioengineering, Grant/ Award Numbers: U24EB028984, R00EB021349, R21EB017338; National Institute of Child Health and Human Development, Grant/Award Numbers: HD099846, HD093578, HD085813; Austrian Science Funds, Grant/Award Number: J 4124-N36

Abbreviations used:

2HG

D-2-hydroxyglutarate

2SH

second-order spherical harmonics

ASE

adiabatic spin echo

CNR

contrast-to-noise ratio

CRLB

Cramér–Rao lower bounds

CV

coefficient of variation

DESS

dual echo steady state

FLAIR

FLuid-Attenuated Inversion Recovery

FOV

field of view

Glx

glutamate and glutamine

GOIA-W

GOIA-WURST gradient offset independent wideband uniform rate and smooth truncation

HGSB

hypergeometric single band

IDH

isocitrate dehydrogenase

MEMPRAGE

multiecho magnetization prepared rapid gradient echo

MRSI

magnetic resonance spectroscopic imaging

RF

radio frequency

ROI

region of interest

SNR

signal-to-noise ratio

SVS

single voxel spectroscopy

tCr

total creatine

TI

inversion time

tNAA

total N-acetyl aspartate

WET

water suppression enhanced through T1 effects

Footnotes

SUPPORTING INFORMATION

Additional supporting information may be found in the online version of the article at the publisher’s website.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

REFERENCES

  • 1.Andronesi OC, Arrillaga-Romany IC, Ly KI, et al. Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate. Nat Commun. 2018;9(1):1474–1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Jafari-Khouzani K, Loebel F, Bogner W, et al. Volumetric relationship between 2-Hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients. Neuro Oncol. 2016;18(11):1569–1578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Andronesi OC, Loebel F, Bogner W, et al. Treatment response assessment in IDH-mutant glioma patients by non-invasive 3D functional spectroscopic mapping of 2-hydroxyglutarate. Clin Cancer Res. 2016;22(7):1632–1641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.de la Fuente MI, Young RJ, Rubel J, et al. Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma. Neuro Oncol. 2016;18(2):283–290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Choi C, Raisanen JM, Ganji SK, et al. Prospective longitudinal analysis of 2-hydroxyglutarate magnetic resonance spectroscopy identifies broad clinical utility for the management of patients with IDH-mutant glioma. J Clin Oncol. 2016;34(33):4030–4039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Dang L, White DW, Gross S, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462(7274):739–744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Parsons DW, Jones S, Zhang XS, et al. An integrated genomic analysis of human glioblastoma Multiforme. Science. 2008;321(5897):1807–1812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Andronesi OC, Kim GS, Gerstner E, et al. Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy. Sci Transl Med. 2012;4(116):116ra4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Choi C, Ganji SK, DeBerardinis RJ, et al. 2-hydroxyglutarate detection by magnetic resonance spectroscopy in subjects with IDH-mutated gliomas. Nat Med. 2012;18(4):624–629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Berrington A, Voets NL, Plaha P, et al. Improved localisation for 2-hydroxyglutarate detection at 3T using long-TE semi-LASER. Tomography. 2016; 2(2):94–105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Branzoli F, Di Stefano AL, Capelle L, et al. Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy. Neuro Oncol. 2018;20(7):907–916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.An Z, Ganji SK, Tiwari V, et al. Detection of 2-hydroxyglutarate in brain tumors by triple-refocusing MR spectroscopy at 3T in vivo. Magn Reson Med. 2017;78(1):40–48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Choi C, Ganji S, Hulsey K, et al. A comparative study of short- and long-TE (1)H MRS at 3 T for in vivo detection of 2-hydroxyglutarate in brain tumors. NMR Biomed. 2013;26(10):1242–1250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Li X, Strasser B, Jafari-Khouzani K, et al. Super-resolution whole-brain 3D MR spectroscopic imaging for mapping D-2-hydroxyglutarate and tumor metabolism in isocitrate dehydrogenase 1-mutated human gliomas. Radiology. 2020;294(3):589–597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Steel A, Chiew M, Jezzard P, et al. Metabolite-cycled density-weighted concentric rings k-space trajectory (DW-CRT) enables high-resolution 1 H magnetic resonance spectroscopic imaging at 3-Tesla. Sci Rep. 2018;8(1):7792–7802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.An Z, Tiwari V, Baxter J, et al. 3D high-resolution imaging of 2-hydroxyglutarate in glioma patients using DRAG-EPSI at 3T in vivo. Magn Reson Med. 2019;81(2):795–802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Aghaeifar A, Mirkes C, Bause J, et al. Dynamic B0 shimming of the human brain at 9.4 T with a 16-channel multi-coil shim setup. Magn Reson Med. 2018;80(4):1714–1725. [DOI] [PubMed] [Google Scholar]
  • 18.Pan JW, Lo KM, Hetherington HP. Role of very high order and degree B0 shimming for spectroscopic imaging of the human brain at 7 Tesla. Magn Reson Med. 2012;68(4):1007–1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Juchem C, Nixon TW, McIntyre S, Boer VO, Rothman DL, de Graaf RA. Dynamic multi-coil shimming of the human brain at 7 T. J Magn Reson. 2011; 212(2):280–288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Stockmann JP, Witzel T, Keil B, et al. A 32-channel combined RF and B0 shim array for 3T brain imaging. Magn Reson Med. 2016;75(1):441–451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Truong TK, Darnell D, Song AW. Integrated RF/shim coil array for parallel reception and localized B0 shimming in the human brain. Neuroimage. 2014; 103:235–240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fillmer A, Kirchner T, Cameron D, Henning A. Constrained image-based B0 shimming accounting for “local minimum traps” in the optimization and field inhomogeneities outside the region of interest. Magn Reson Med. 2015;73(4):1370–1380. [DOI] [PubMed] [Google Scholar]
  • 23.Hetherington HP, Chu WJ, Gonen O, Pan JW. Robust fully automated shimming of the human brain for high-field 1H spectroscopic imaging. Magn Reson Med. 2006;56(1):26–33. [DOI] [PubMed] [Google Scholar]
  • 24.Kirchner T, Fillmer A, Henning A. Mechanisms of SNR and line shape improvement by B0 correction in overdiscrete MRSI reconstruction. Magn Reson Med. 2017;77(1):44–56. [DOI] [PubMed] [Google Scholar]
  • 25.Ebel A, Maudsley AA, Schuff N. Correction of local B0 shifts in 3D EPSI of the human brain at 4 T. Magn Reson Imaging. 2007;25(3):377–380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Liu Y, Ma C, Clifford B, Lam F, Johnson CL, Liang ZP. Field-inhomogeneity-corrected low-rank filtering of magnetic resonance spectroscopic imaging data. IEEE Eng Med Biol Soc Annual Conf. 2014;2014:6422–6425. [DOI] [PubMed] [Google Scholar]
  • 27.Juchem C, Green D, de Graaf RA. Multi-coil magnetic field modeling. J Magn Reson. 2013;236:95–104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Arango N, Stockman J & Strasser B et al. Dynamically switched B0 field control for separate optimization of tailored volume lipid suppression and B0 homogeneity for brain chemical shift imaging at 3T using multi-coil shim array. Proceedings of the 26th Annual Meeting of ISMRM, Paris, France; 2018. Abstract #1062. [Google Scholar]
  • 29.Esmaeili M, Stockmann J, Strasser B, et al. An integrated RF-receive/B(0)-shim array coil boosts performance of whole-brain MR spectroscopic imaging at 7 T. Sci Rep. 2020;10(1):15029–15046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.de Graaf RA, Brown PB, De Feyter HM, McIntyre S, Nixon TW. Elliptical localization with pulsed second-order fields (ECLIPSE) for robust lipid suppression in proton MRSI. NMR Biomed. 2018;31(9):e3949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Boer VO, van de Lindt T, Luijten PR, Klomp DW. Lipid suppression for brain MRI and MRSI by means of a dedicated crusher coil. Magn Reson Med. 2015;73(6):2062–2068. [DOI] [PubMed] [Google Scholar]
  • 32.Arango N, Stockmann JP, Witzel T, Wald L & White J Open-source, low-cost, flexible, current feedback-controlled driver circuit for local B0 shim coils and other applications. Proceedings of the 24th ISMRM Scientific Meeting, 3–7 May, Singapore; 2016. Abstract #1157. [Google Scholar]
  • 33.Jenkinson M Fast, automated, N-dimensional phase-unwrapping algorithm. Magn Reson Med. 2003;49:193–197. [DOI] [PubMed] [Google Scholar]
  • 34.Esmaeili M, Bathen TF, Rosen BR, Andronesi OC. Three-dimensional MR spectroscopic imaging using adiabatic spin echo and hypergeometric dualband suppression for metabolic mapping over the entire brain. Magn Reson Med. 2017;77(2):490–497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Degraaf RA, Luo Y, Terpstra M, Merkle H, Garwood M. A new localization method using an adiabatic pulse, Bir-4. J Magn Reson B. 1995;106(3): 245–252. [DOI] [PubMed] [Google Scholar]
  • 36.Andronesi OC, Ramadan S, Ratai EM, Jennings D, Mountford CE, Sorensen AG. Spectroscopic imaging with improved gradient modulated constant adiabaticity pulses on high-field clinical scanners. J Magn Reson. 2010;203(2):283–293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Rosenfeld D, Panfil SL, Zur Y. Design of selective adiabatic inversion pulses using the adiabatic condition. J Magn Reson. 1997;129(2):115–124. [DOI] [PubMed] [Google Scholar]
  • 38.Ebel A, Govindaraju V, Maudsley AA. Comparison of inversion recovery preparation schemes for lipid suppression in H-1 MRSI of human brain. Magn Reson Med. 2003;49(5):903–908. [DOI] [PubMed] [Google Scholar]
  • 39.Ogg RJ, Kingsley PB, Taylor JS. WET, a T-1-insensitive and B-1-insensitive water-suppression method for in-vivo localized H-1-NMR spectroscopy. J Magn Reson B. 1994;104(1):1–10. [DOI] [PubMed] [Google Scholar]
  • 40.Bogner W, Hess AT, Gagoski B, et al. Real-time motion- and B-correction for LASER-localized spiral-accelerated 3D-MRSI of the brain at 3T. Neuroimage. 2013;88C:22–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.van der Kouwe AJW, Benner T, Salat DH, Fischl B. Brain morphometry with multiecho MPRAGE. Neuroimage. 2008;40(2):559–569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Mayer D, Levin YS, Hurd RE, Glover GH, Spielman DM. Fast metabolic imaging of systems with sparse spectra: application for hyperpolarized 13C imaging. Magn Reson Med. 2006;56(4):932–937. [DOI] [PubMed] [Google Scholar]
  • 43.Hoge RD, Kwan RK, Pike GB. Density compensation functions for spiral MRI. Magn Reson Med. 1997;38(1):117–128. [DOI] [PubMed] [Google Scholar]
  • 44.Beatty PJ, Nishimura DG, Pauly JM. Rapid gridding reconstruction with a minimal oversampling ratio. IEEE Trans Med Imaging. 2005;24(6):799–808. [DOI] [PubMed] [Google Scholar]
  • 45.Provencher SW. Estimation of metabolite concentrations from localized in-vivo proton NMR-spectra. Magn Reson Med. 1993;30(6):672–679. [DOI] [PubMed] [Google Scholar]
  • 46.Smith SA, Levante TO, Meier BH, Ernst RR. Computer-simulations in magnetic-resonance - an object-oriented programming approach. J Magn Reson A. 1994;106(1):75–105. [Google Scholar]
  • 47.de Graaf RA, Rothman DL. In vivo detection and quantification of scalar coupled 1H NMR resonances. Concepts Magn Reson. 2001;13(1):32–76. [Google Scholar]
  • 48.Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004; 23(Suppl 1):S208–S219. [DOI] [PubMed] [Google Scholar]
  • 49.Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000;13(3):129–153. [DOI] [PubMed] [Google Scholar]
  • 50.Bal D, Gryff-Keller A. 1H and 13C NMR study of 2-hydroxyglutaric acid and its lactone. Magn Reson Chem. 2002;40(8):533–536. [Google Scholar]
  • 51.Capper D, Zentgraf H, Balss J, Hartmann C, von Deimling A. Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol. 2009;118(5): 599–601. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

RESOURCES